Search results for "Cardiology"
IDSA guidelines, experts address hydroxychloroquine, other potential COVID-19 therapies
The Infectious Diseases Society of America (IDSA) made recommendations on using drugs to treat COVID-19, while cardiac groups warned about risks of arrhythmias with hydroxychloroquine and azithromycin.
https://acphospitalist.acponline.org/weekly/archives/2020/04/15/1.htm
15 Apr 2020
Malpractice and syncope, heart failure and fracking
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2021/03/in-the-news.htm
15 Mar 2021
A bit of good news on drug costs
Recent Medicare changes may help more patients access guideline-directed heart failure therapies, a study found.
https://acphospitalist.acponline.org/archives/2023/02/15/a-bit-of-good-news-on-drug-costs.htm
15 Feb 2023
Latest research shows impact of COVID-19 on other health care
Hospitalizations for stroke and myocardial infarction, ED visits, cancer diagnoses, and trials for conditions other than COVID-19 all dropped during the pandemic, recent studies showed.
https://acphospitalist.acponline.org/weekly/archives/2020/08/12/1.htm
12 Aug 2020
Sex differences prevalent in acute MI presentation and treatment
One recent study looked at outcomes after acute myocardial infarction (MI) in older men compared to women, while another examined the effect of sex-specific diagnostic thresholds for high-sensitivity cardiac troponin I.
https://acphospitalist.acponline.org/weekly/archives/2019/10/23/3.htm
23 Oct 2019
COVID-19 in community hospitals
Hospitalists describe the steps they've taken to prepare for the pandemic.
https://acphospitalist.acponline.org/archives/2020/04/covid-19-in-community-hospitals.htm
15 Apr 2020
The battle for high-value care
Experts give their advice on value projects and the evidence on stress tests and clot prophylaxis.
https://acphospitalist.acponline.org/archives/2019/12/the-battle-for-high-value-care.htm
15 Dec 2019
Cardiac troponin test may not safely rule out inducible myocardial ischemia in symptomatic patients with stable CAD, study finds
An accompanying editorial questioned whether coronary artery stenoses need to be diagnosed in stable coronary artery disease (CAD), since revascularization won't benefit such patients but may cause harm.
https://acphospitalist.acponline.org/weekly/archives/2020/01/08/1.htm
8 Jan 2020
Continuing aspirin for no reason?
A speaker made the case for anticoagulant monotherapy in selected patients with stable coronary artery disease and atrial fibrillation during a “Things We Do For No Reason” session at SHM Converge 2022.
https://acphospitalist.acponline.org/archives/2022/04/27/continuing-aspirin-for-no-reason.htm
27 Apr 2022
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a trial, new studies suggested looking out for myocardial injury and not overdoing thromboprophylaxis, and remdesivir got full approval, among other COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2020/10/28/1.htm
28 Oct 2020